Notify me when Christopher Thomas Giordano files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| TENX | TENAX THERAPEUTICS, INC. | Common Stock, $0.0001 par value per share | 6.8% | $16,288,545 | 1,252,965 | Christopher Thomas Giordano | 10 Dec 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|